Close Menu

WASHINGTON (GenomeWeb News) – Small studies, sometimes containing a single patient, can be applied to unravel the biological mechanisms behind cancer drug response as well as identify possible drug treatments for a specific cancer type, according to researchers.

While such small studies may be dismissed by some as anecdotes, panelists at an afternoon session yesterday at the American Association for Cancer Research annual meeting here argued that such studies can be used to resurrect abandoned drugs and to reveal known drugs to which a tumor may be susceptible.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

In Science this week: whole-genome sequencing of single sperm cells, and more.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost. 

Apr
30
Sponsored by
Lexogen

This webinar will discuss novel long-read transcript sequencing (LRTseq) methods for transcriptome annotation that could increase the efficiency and accuracy of future sequencing projects.

May
08
Sponsored by
Sysmex Inostics

This webinar will present recent evidence that demonstrates how incorporating circulating tumor DNA (ctDNA) assessments into real-world patient management can influence patient care decisions, alter radiographic interpretations, and impact clinical outcomes.